MARKET DATA 2022 - 2030
PELVIC HEALTH &
PASSIVE FITNESS
- With such a broad therapeutic scope, and significant ongoing improvements in biotechnology, it is not surprising that neuromodulation is poised as a major growth industry for the next decade.
- Incontinence segment expected to grow annually by 75%
- Erectile Dysfunction Market poised to 4.73 billion by 2030,
- The Female Sexual Dysfunction Market is expected to grow by $7760.77 mn
- The global erectile dysfunction market (CAGR) of 8.5% from 2022 to 2030.
- The body fat reduction market was valued at USD 7.93 billion in 2021 and is expected to grow at a CAGR of 7.8%
- The global cellulite treatment market size was valued at USD 1.25 billion in 2021 and is expected to expand at a compound annual growth rate (CAGR) of 11.3% from 2022 to 2030. USD 3.4 Billion
Body Fat Reduction Market Share, Size & Trends
The global body fat reduction market was valued at USD 7.93 billion in 2021 and is expected to grow at a CAGR of 7.8% during the forecast period. The increasing pace of obesity is one of the major key forces that intensify market growth significantly. The awareness concerning the requirement to re-shape and tone their body and lower the additional fat content is rising, therefore providing an upthrust to the body fat reduction market.
Non-invasive fat reduction is a fat reduction procedure that is done to decrease or eliminate the stubborn fat pockets in specific areas of the body by using methods like HIFEM, RF, radiofrequency, cryolipolysis, and laser lipolysis. Non-invasive devices that are used in these procedures
Body Fat Reduction Market Share, Size & Trends
The global body fat reduction market was valued at USD 7.93 billion in 2021 and is expected to grow at a CAGR of 7.8% during the forecast period. The increasing pace of obesity is one of the major key forces that intensify market growth significantly. The awareness concerning the requirement to re-shape and tone their body and lower the additional fat content is rising, therefore providing an upthrust to the body fat reduction market.
Non-invasive fat reduction is a fat reduction procedure that is done to decrease or eliminate the stubborn fat pockets in specific areas of the body by using methods like HIFEM, RF, radiofrequency, cryolipolysis, and laser lipolysis. Non-invasive devices that are used in these procedures
FREEDOM+™ PFM Monetization ROI - Suggested Cost Per Treatment for Practitioners & Pricing Structure
FREEDOM+™ RF-PFM treatment consists of two treatment sessions of 30 minutes twice a week for 3 weeks (a total of 6 sessions). The cost of the full treatment ranges from $2400 to $3000.
FREEDOM+™ HIFEM RF Sculpt Pro™ costs $3,000 on average, (according to 459 reviews from RealSelf members), alternatively, the price can range from $750 for a single 30-minute HIFEM treatment to $6,000 for multiple treatment sessions.
FREEDOM+™ HIFEM RF Sculpt Pro™ $1,000 per treatment session, on average, though some providers charge as much as 50% more for a RF treatment than a standard HIFEM session.
Compared to the original device, this newer technology is more expensive because it delivers up to 20% more electromagnetic pulses and adds radiofrequency energy, to reduce fat and build muscle more efficiently.
FREEDOM+™ PFM Monetization ROI - Suggested Cost Per Treatment for Practitioners & Pricing Structure
FREEDOM+™ RF-PFM treatment consists of two treatment sessions of 30 minutes twice a week for 3 weeks (a total of 6 sessions). The cost of the full treatment ranges from $2400 to $3000.
FREEDOM+™ HIFEM RF Sculpt Pro™ costs $3,000 on average, (according to 459 reviews from RealSelf members), alternatively, the price can range from $750 for a single 30-minute HIFEM treatment to $6,000 for multiple treatment sessions.
FREEDOM+™ HIFEM RF Sculpt Pro™ $1,000 per treatment session, on average, though some providers charge as much as 50% more for a RF treatment than a standard HIFEM session.
Compared to the original device, this newer technology is more expensive because it delivers up to 20% more electromagnetic pulses and adds radiofrequency energy, to reduce fat and build muscle more efficiently.
Cellulite Industry
Market Data
- The global cellulite treatment market size was valued at USD 1.25 billion in 2021 and is expected to expand at a compound annual growth rate (CAGR) of 11.3% from 2022 to 2030. USD 3.4 Billion
- Increasing demand for cosmetic and aesthetic procedures along with the rise in the obese population is anticipated to fuel the industry growth.
Cellulite Industry Market Data
- The global cellulite treatment market size was valued at USD 1.25 billion in 2021 and is expected to expand at a compound annual growth rate (CAGR) of 11.3% from 2022 to 2030. USD 3.4 Billion
- Increasing demand for cosmetic and aesthetic procedures along with the rise in the obese population is anticipated to fuel the industry growth.
INCONTINENCE AND SEXUAL DYSFUNCTION
The increasing burden of lifestyle diseases and rising adoption of a sedentary lifestyle are responsible for the increasing incidence of Erectile Dysfunction (ED) worldwide. According to World Health Organization (WHO) report, around 15% of the male population were reported to be affected by erectile dysfunction every year which is projected to reach 320 million by 2025.
- Revenue in the Incontinence segment amounts to US$4.06bn in 2023. The market is expected to grow annually by 75% (CAGR 2023-2027).
- The global incontinence care products market size was valued at USD 14.30 billion in 2018 and is projected to reach USD 24.35 billion by 2026, exhibiting a CAGR of 6.9% during the forecast period.
- Erectile Dysfunction Market size was valued at USD 2.3 billion in 2021and is poised to grow from USD 2.49 billion in 2022 to USD 4.73 billion by 2030, growing at a CAGR of 8.5% in the forecast period (2023-2030).
- The Female Sexual Dysfunction Treatment Market is expected to grow by $7760.77 mn during 2023-2027, accelerating at a CAGR of 34.28% during the forecast period
- The global erectile dysfunction drugs market was valued at USD 2.30 billion in 2021 and is expected to expand at a compounded annual growth rate (CAGR) of 8.5% from 2022 to 2030.
INCONTINENCE AND SEXUAL DYSFUNCTION
- Revenue in the Incontinence segment amounts to US$4.06bn in 2023. The market is expected to grow annually by 75% (CAGR 2023-2027).
- The global incontinence care products market size was valued at USD 14.30 billion in 2018 and is projected to reach USD 24.35 billion by 2026, exhibiting a CAGR of 6.9% during the forecast period.
- Erectile Dysfunction Market size was valued at USD 2.3 billion in 2021and is poised to grow from USD 2.49 billion in 2022 to USD 4.73 billion by 2030, growing at a CAGR of 8.5% in the forecast period (2023-2030).
- The Female Sexual Dysfunction Treatment Market is expected to grow by $7760.77 mn during 2023-2027, accelerating at a CAGR of 34.28% during the forecast period
- The global erectile dysfunction drugs market was valued at USD 2.30 billion in 2021 and is expected to expand at a compounded annual growth rate (CAGR) of 8.5% from 2022 to 2030.
The increasing burden of lifestyle diseases and rising adoption of a sedentary lifestyle are responsible for the increasing incidence of Erectile Dysfunction (ED) worldwide. According to World Health Organization (WHO) report, around 15% of the male population were reported to be affected by erectile dysfunction every year which is projected to reach 320 million by 2025.
